N@N

Market Maker Surveillance Report. GNBT, MTG, RHI, TLB, AFFY, BFAR, Highest Net Buy Volume With Lowest Price Friction For Thurs

^{Published on 2011-12-08 18:00:29 - WOPRAI}
 

December 8, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 3501 companies with "abnormal" market making, 1283 companies with positive Friction Factors and 4994 companies with negative Friction Factors. Here is a list of the top companies with the highest net buy volume on Thursday and lowest price Friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. GENEREX BIOTECHNOLOGY CORP (NASDAQ:GNBT), MGIC INVESTMENT CORP (NYSE:MTG), ROBERT HALF INTL INC (NYSE:RHI), TALBOTS INC (NYSE:TLB), AFFYMAX INC (NASDAQ:AFFY), BIOPHARM ASIA INC (OTC:BFAR). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     GNBT       $0.017       20.48%       4,823,892       63.81%       2,734,729       36.17%       2,089,163       1,214,630
     MTG        $0.010       0.28%        4,642,096       32.69%       4,161,806       29.30%       480,290         480,290 
     RHI        $0.030       0.11%        1,210,556       42.71%       743,873         26.24%       466,683         155,561 
     TLB        $0.100       3.77%        1,424,769       40.65%       950,352         27.11%       474,417         47,442  
     AFFY       $2.140       36.57%       10,792,689      50.35%       10,327,936      48.18%       464,753         2,172   
     BFAR       $0.017       18.75%       611,528         82.34%       131,134         17.66%       480,394         291,148 

For example, the chart above shows GNBT with a Net Buy Volume of 2,089,163 shares and a Friction Factor of 1,214,630 shares. That means that it takes 1,214,630 more shares of buying than selling to move GNBT higher by one penny. This means the Market Makers are allowing the stock to move up higher as of Thursday (lower friction). And with one of the highest Net Buy Volumes, the combination of low friction and high net buy volume is bullish.

GENEREX BIOTECHNOLOGY CORP (NASDAQ:GNBT) - Generex Biotechnology Corporation, a development stage company, engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases. It develops a proprietary platform technology for the oral administration of large molecule drugs, including proteins, peptides, monoclonal antibodies, hormones, and vaccines. The companys products include Generex Oral-lyn, an insulin spray formulation used for the treatment of Type-1 and Type-2 diabetes; Glucose RapidSpray, which provides an alternative for people who require additional glucose in their diet, as well as delivers glucose formulation directly into the mouth; BaBOOM! Energy Spray, an instant energy spray designed to increase energy levels for sports, work, study, travel, and overall fatigue; and Crave-NX, a fat-free glucose spray that is used as an aid for dieters. Generex Biotechnology Corporations under development products include medicinal chewing gum for the treatment of Type-2 diabetes mellitus and obesity; morphine and fentanyl products for breakthrough and postoperative pain; and AE37, an immunotherapeutic vaccine that is in Phase II clinical trials for patients with HER-2/neu positive breast cancer. The company markets its products through distributors and retail chains in Ecuador, Canada, and the United States. It has collaboration with Fertin Pharma A/S for the development of a metformin medicinal chewing gum. The company was founded in 1983 and is based in Toronto, Canada.

MGIC INVESTMENT CORP (NYSE:MTG) - MGIC Investment Corporation, through its subsidiary, Mortgage Guaranty Insurance Corporation, provides private mortgage insurance to the home mortgage lending industry in the United States. It provides primary insurance coverage that provides mortgage default protection on individual loans and covers unpaid loan principal, delinquent interest, and various expenses associated with the default and subsequent foreclosure. The companys primary insurance is written on first mortgage loans secured by owner occupied single-family homes, first liens secured by non-owner occupied single-family homes, and on vacation or second homes. MGIC Investments principal product, primary mortgage insurance is written through the flow market channel, in which loans are insured in individual and loan-by-loan transactions, as well as through the bulk market channel, in which portfolios of loans are individually insured in single, bulk transactions. It also provides various mortgage services for the mortgage finance industry, such as contract underwriting, portfolio retention, and secondary marketing of mortgage-related assets. In addition, the company provides Internet portal that enables mortgage originators to access products and services of wholesalers, investors, and vendors necessary to make a home mortgage loan, as well as provides Web site hosting, design, and marketing solutions for mortgage originators and real estate agents. It serves originators of residential mortgage loans, such as savings institutions, commercial banks, mortgage brokers, credit unions, mortgage bankers, and various other lenders. The company was founded in 1984 and is headquartered in Milwaukee, Wisconsin.

ROBERT HALF INTL INC (NYSE:RHI) - Robert Half International Inc. provides staffing and risk consulting services in North America, South America, Europe, Asia, and Australia. Its Accountemps division offers temporary staffing in the fields of accounting, tax, and finance. The companys OfficeTeam division places temporary and full-time office and administrative personnel, ranging from word processors to office managers. Its Robert Half Finance & Accounting division specializes in the placement of full-time accounting, financial, tax, and banking personnel. The companys Robert Half Technology division specializes in providing information technology contract consultants; and placing full-time employees in the areas, ranging from multiple platform systems integration to end-user support, including specialists in programming, networking, systems integration, database design, and help desk support. Its Robert Half Legal division places temporary and full-time employees in attorney, paralegal, legal administrative, and legal secretarial positions. The companys Robert Half Management Resources division offers senior level project professionals in the accounting and finance fields comprising chief financial officers, controllers, and senior financial analysts for various tasks, such as financial systems conversions, expansion into new markets, business process reengineering, and post-merger financial consolidation. Its Creative Group division serves clients in the areas of advertising, marketing, and Web design; and places project consultants in various positions consisting of creative directors, graphics designers, Web content developers, Web designers, media buyers, and public relations specialists. The companys Protiviti division provides experts specializing in risk, advisory, and transactional services. Robert Half International was founded in 1948 and is based in Menlo Park, California.

TALBOTS INC (NYSE:TLB) - The Talbots, Inc., together with its subsidiaries, operates as a specialty retailer and direct marketer of womens apparel, accessories, and shoes in the United States and Canada. It offers classic sportswear, casual wear, dresses, coats, sweaters, accessories, and shoes in misses, petites, woman, and woman petite sizes. The company also markets its products online through its Web site, talbots.com, as well as through catalogs. As of January 30, 2010, it operated 580 stores under the Talbots brand name. The company was founded in 1947 and is headquartered in Hingham, Massachusetts.

AFFYMAX INC (NASDAQ:AFFY) - Affymax, Inc., a biopharmaceutical company, engages in the development of drugs for the treatment of serious and life-threatening conditions. The company is developing Hematide, which is in Phase III clinical trials for the treatment of anemia associated with chronic renal failure. Hematide is a synthetic peptide-based erythropoiesis stimulating agent designed to stimulate production of red blood cells. Affymax, Inc. has strategic alliance agreements with Takeda Pharmaceutical Company Limited and Nektar Therapeutics AL, Corporation to manufacture, develop, and commercialize Hematide. The company was founded in 2001 and is based in Palo Alto, California.

BIOPHARM ASIA INC (OTC:BFAR) - BioPharm Asia, Inc. engages in the sale of medical products to drug stores, hospitals, neighborhood clinics, and other medicine retail outlets in the Peoples Republic of China. Its products include approximately 300 prescription drugs; approximately 1,150 over the counter drugs comprising western medicines and traditional Chinese medicines for the treatment of common diseases; approximately 85 nutritional supplements consisting of healthcare supplements, vitamins, minerals, and dietary products; and various types of drinkable herbal remedies and packages of assorted herbs for making soup, which are used by consumers as health supplements. The companys other products comprise personal care products, such as skin care, hair care, and beauty products; family care products, including portable medical devices for family use, birth control, and early pregnancy test products; convenience products, including soft drinks, packaged snacks, and other consumables; and cleaning agents and stationery, as well as seasonal and promotional items. As of December 31, 2009, it operated 360 retail drug stores. The company also involves in the cultivation of Chinese herbal medicines; production and sale of herbal and pharmaceutical products; and wholesale distribution of pharmaceutical and healthcare products. BioPharm Asia, Inc. is based in Tonghua County, the Peoples Republic of China.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net